Latest MS Stories
Genzyme/Sanofi's Lemtrada and Genentech/Roche's Ocrelizumab Will Likely Be Reserved for Patients with Aggressive/Severe MS, According to Findings from Decision Resources Group BURLINGTON, Mass.,
FAIRFIELD, Conn., July 22, 2014 /PRNewswire/ -- An estimated 2.3 million people worldwide live with multiple sclerosis
CINCINNATI, July 21, 2014 /PRNewswire/ -- An estimated 2.3 million people worldwide live with multiple sclerosis
Every Month Hands-On Physical Therapy Raises Money for an Important Cause: This Month Was the Fight Against Multiple Sclerosis Astoria, New York (PRWEB) July
DailyGossip.org publishes a useful review to the Natural Multiple Sclerosis Cure program to help patients find a way to feel better and eliminate symptoms Denver,
MISSISSAUGA, ON, June 25, 2014 /CNW/ - Biogen Idec Canada announces today that TECFIDERA(TM) (dimethyl fumarate) is now available for reimbursement in British Columbia (B.C.) through B.C.
Scientists in the University of Connecticut’s Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease.
11 Friedman Fellows are presenting their work on some of the most cutting-edge diabetes and food & nutrition research in the country, ranging from the role of vitamin D in diabetes, to diabetes
DailyGossip.org publishes a complex review to a new method of curing multiple sclerosis.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.
More Images (2 images) »